Trump's Drug Price Controls Could Ground Innovation To a Halt

Americans are notoriously unhappy with healthcare. As of last December, Americans’ perception of the quality of US healthcare hit a new low, with 54% of the population reporting to Gallup that quality is either fair or poor. Coverage is viewed even more poorly than quality, and it has slowly brought the Republican Party of President Trump to a position where their message is identical to that of socialist Senator Bernie Sanders. President Trump began the week by tearing into American pharmaceutical firms, accusing them of “profiteering and price gouging”. 

 

Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes